Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year.

Demis Hassabis, the cofounder and CEO of DeepMind, is one of three researchers ... "I hope we'll look back on AlphaFold as the first proof point of AI's incredible potential to accelerate ...